IWC
DNA icon

Integrated Wealth Concepts’s Ginkgo Bioworks DNA Stock Holding History

Integrated Wealth Concepts’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8K Buy
+5,023
New +$42K ﹤0.01% 3364

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Integrated Wealth Concepts's DNA Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 5,023 shares worth $49.8K. The stake represents ﹤0.01% of the portfolio and ranks #3364 among its holdings.

184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Integrated Wealth Concepts held 5,023 shares of Ginkgo Bioworks worth $49.8K as of Q2 2026.
  • Ginkgo Bioworks was a new Integrated Wealth Concepts position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3364 holding.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.